Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Common Equity (2023 - 2026)

Astera Labs has reported Common Equity over the past 3 years, most recently at $1.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 41.34% year-over-year to $1.4 billion, compared with a TTM value of $1.4 billion through Dec 2025, up 41.34%, and an annual FY2025 reading of $1.4 billion, up 41.34% over the prior year.
  • Common Equity came in at $1.4 billion for Q4 2025, up from $1.3 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.4 billion in Q4 2025 to a low of -$117.3 million in Q2 2023.
  • Median Common Equity over the past 3 years was $867.4 million (2024), compared with a mean of $657.5 million.
  • The sharpest move saw Common Equity soared 1087.5% in 2024, then grew 28.78% in 2025.
  • Over 3 years, Common Equity stood at -$97.7 million in 2023, then soared by 1087.5% to $964.8 million in 2024, then soared by 41.34% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ALAB's Common Equity are $1.4 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.1 billion (Q2 2025).